Cite
HARVARD Citation
Montgomery, H. et al. (2022). Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet. 10 (10), pp. 985-996. [Online].